The Cochrane Library: Cochrane Database of Systematic Reviews

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia, Critical and Emergency Care Group
  4. Cochrane Back and Neck Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Common Mental Disorders Group
  10. Cochrane Consumers and Communication Group
  11. Cochrane Cystic Fibrosis and Genetic Disorders Group
    1. About this group
    2. Reviews
      1. Active cycle of breathing technique for cystic fibrosisReview
      2. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell diseaseReview
      3. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosisReview
      4. Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritisReview
      5. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosisReview
      6. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosisReview
      7. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbationReview
      8. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosisReview
      9. Antibiotic treatment for Stenotrophomonas maltophilia in people with cystic fibrosisReview
      10. Antibiotics for treating acute chest syndrome in people with sickle cell diseaseReview
      11. Antibiotics for treating community acquired pneumonia in people with sickle cell diseaseReview
      12. Antibiotics for treating osteomyelitis in people with sickle cell diseaseReview
      13. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractionsReview
      14. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosisReview
      15. Antioxidant supplementation for lung disease in cystic fibrosisReview
      16. Appetite stimulants for people with cystic fibrosisReview
      17. Bisphosphonate therapy for osteogenesis imperfectaReview
      18. Bisphosphonates for osteoporosis in people with cystic fibrosisReview
      19. Blood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseReview
      20. Blood transfusions for treating acute chest syndrome in people with sickle cell diseaseReviewNew Search
      21. Bronchoscopy-guided antimicrobial therapy for cystic fibrosisReview
      22. Carnitine supplementation for inborn errors of metabolismReview
      23. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosisReview
      24. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosisReview
      25. Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or BReview
      26. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosisReview
      27. Conjugate Haemophilus influenzae type b vaccines for sickle cell diseaseReview
      28. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosisReview
      29. Deferasirox for managing iron overload in people with thalassaemiaReview
      30. Deferasirox for managing transfusional iron overload in people with sickle cell diseaseReview
      31. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemiaReview
      32. Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disordersReview
      33. Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adultsReview
      34. Dietary interventions for phenylketonuriaReview
      35. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemiaReview
      36. Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritisReview
      37. Dornase alfa for cystic fibrosisReview
      38. Drug therapies for reducing gastric acidity in people with cystic fibrosisReviewNew Search
      39. Drugs for preventing red blood cell dehydration in people with sickle cell diseaseReview
      40. Duration of intravenous antibiotic therapy in people with cystic fibrosisReviewNew Search
      41. Elective versus symptomatic intravenous antibiotic therapy for cystic fibrosisReview
      42. Embolisation for pulmonary arteriovenous malformationReview
      43. Enteral tube feeding for cystic fibrosisReview
      44. Enzyme replacement and substrate reduction therapy for Gaucher diseaseReview
      45. Enzyme replacement therapy for Anderson-Fabry diseaseReview
      46. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VIReview
      47. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)Review
      48. Enzyme replacement therapy with laronidase (Aldurazyme®) for treating mucopolysaccharidosis type IReview
      49. Eradication therapy for Burkholderia cepacia complex in people with cystic fibrosisReview
      50. Fluid replacement therapy for acute episodes of pain in people with sickle cell diseaseReview
      51. Folate supplementation in people with sickle cell diseaseReview
      52. Gene therapy for haemophiliaReview
      53. Gene therapy for sickle cell diseaseReview
      54. Hematopoietic stem cell transplantation for Gaucher diseaseReview
      55. Hematopoietic stem cell transplantation for people with ß-thalassaemia majorReview
      56. Hematopoietic stem cell transplantation for people with sickle cell diseaseReview
      57. Home versus hospital intravenous antibiotic therapy for cystic fibrosisReview
      58. Hydroxyurea for sickle cell diseaseReview
      59. Immune tolerance induction for treating inhibitors in people with congenital haemophilia A or BReview
      60. Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosisReview
      61. Inhaled antibiotics for long-term therapy in cystic fibrosisReview
      62. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosisReview
      63. Inhaled bronchodilators for acute chest syndrome in people with sickle cell diseaseReviewNew Search
      64. Inhaled bronchodilators for cystic fibrosisReviewWithdrawn
      65. Inhaled corticosteroids for cystic fibrosisReviewNew Search
      66. Inhaled mannitol for cystic fibrosisReview
      67. Inhaled nitric oxide for acute chest syndrome in people with sickle cell diseaseReview
      68. Inspiratory muscle training for cystic fibrosisReview
      69. Insulin and oral agents for managing cystic fibrosis-related diabetesReview
      70. Interventions for promoting physical activity in people with cystic fibrosisReview
      71. Interventions for reducing inflammation in familial Mediterranean feverReview
      72. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosisReview
      73. Interventions for treating acute bleeding episodes in people with acquired hemophilia AReview
      74. Interventions for treating intrahepatic cholestasis in people with sickle cell diseaseReview
      75. Interventions for treating leg ulcers in people with sickle cell diseaseReview
      76. Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosisReview
      77. Laser therapy for retinopathy in sickle cell diseaseReview
      78. Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell diseaseReview
      79. Macrolide antibiotics for cystic fibrosisReview
      80. Maternal and foetal outcomes following natural vaginal versus caesarean section (c-section) delivery in women with bleeding disorders and carriersReview
      81. Nebulised hypertonic saline for cystic fibrosisReview
      82. Nebuliser systems for drug delivery in cystic fibrosisReview
      83. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosisReview
      84. Neonatal screening for sickle cell diseaseReview
      85. Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosisReview
      86. Newborn screening for cystic fibrosisReview
      87. Newborn screening for homocystinuriaReview
      88. Non-invasive ventilation for cystic fibrosisReview
      89. Non-surgical interventions for treating heavy menstrual bleeding (menorrhagia) in women with bleeding disordersReview
      90. Omega-3 fatty acids for cystic fibrosisReview
      91. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosisReview
      92. Oral anti-pseudomonal antibiotics for cystic fibrosisReview
      93. Oral calorie supplements for cystic fibrosisReview
      94. Oral deferiprone for iron chelation in people with thalassaemiaReview
      95. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosisReview
      96. Oral protein calorie supplementation for children with chronic diseaseReview
      97. Oral steroids for long-term use in cystic fibrosisReview
      98. Oscillating devices for airway clearance in people with cystic fibrosisReview
      99. Oxygen therapy for cystic fibrosisReview
      100. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosisReview
      101. Pancreatic enzyme replacement therapy for people with cystic fibrosisReview
      102. Percutaneous lines for delivering intravenous antibiotics in people with cystic fibrosisReview
      103. Physical exercise training for cystic fibrosisReview
      104. Phytomedicines (medicines derived from plants) for sickle cell diseaseReview
      105. Piracetam for reducing the incidence of painful sickle cell disease crisesReview
      106. Pneumococcal vaccines for cystic fibrosisReviewNew Search
      107. Pneumococcal vaccines for sickle cell diseaseReview
      108. Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosisReview
      109. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosisReview
      110. Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs diseaseReview
      111. Preoperative blood transfusions for sickle cell diseaseReview
      112. Prophylactic anti-staphylococcal antibiotics for cystic fibrosisReview
      113. Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell diseaseReview
      114. Protein substitute for children and adults with phenylketonuriaReview
      115. Psychological interventions for individuals with cystic fibrosis and their familiesReview
      116. Psychological therapies for sickle cell disease and painReview
      117. Psychological therapies for thalassaemiaReview
      118. Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disordersReview
      119. Rapamycin and rapalogs for tuberous sclerosis complexReview
      120. Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitorsReview
      121. Recombinant growth hormone therapy for cystic fibrosis in children and young adultsReview
      122. Recombinant growth hormone therapy for X-linked hypophosphatemia in childrenReview
      123. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell diseaseReview
      124. Rituximab for eradicating inhibitors in people with acquired haemophilia AReview
      125. Rituximab for treating inhibitors in people with inherited severe hemophiliaReview
      126. Sapropterin dihydrochloride for phenylketonuriaReview
      127. Self-management education for cystic fibrosisReview
      128. Singing as an adjunct therapy for children and adults with cystic fibrosisReviewNew Search
      129. Single versus combination intravenous antibiotic therapy for people with cystic fibrosisReview
      130. Sodium channel blockers for cystic fibrosisReview
      131. Splenectomy for people with thalassaemia major or intermediaReview
      132. Splenectomy versus conservative management for acute sequestration crises in people with sickle cell diseaseReview
      133. Standard (head-down tilt) versus modified (without head-down tilt) postural drainage in infants and young children with cystic fibrosisReview
      134. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosisReview
      135. Statins for children with familial hypercholesterolemiaReview
      136. Surgical interventions for treating pectus excavatumReview
      137. Timing of dornase alfa inhalation for cystic fibrosisReview
      138. Timing of hypertonic saline inhalation for cystic fibrosisReview
      139. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung diseaseReview
      140. Topical nasal steroids for treating nasal polyposis in people with cystic fibrosisReview
      141. Totally implantable vascular access devices for cystic fibrosisReview
      142. Treatment for avascular necrosis of bone in people with sickle cell diseaseReviewNew Search
      143. Treatment for chronic methicillin-sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosisReview
      144. Treatment for osteoporosis in people with ß-thalassaemiaReview
      145. Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgeryReview
      146. Treatment of dental complications in sickle cell diseaseReview
      147. Treatments for priapism in boys and men with sickle cell diseaseReview
      148. Tyrosine supplementation for phenylketonuriaReview
      149. Ursodeoxycholic acid for cystic fibrosis-related liver diseaseReview
      150. Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosisReview
      151. Vaccines for preventing influenza in people with cystic fibrosisReview
      152. Vaccines for preventing invasive salmonella infections in people with sickle cell diseaseReview
      153. Vitamin A supplementation for cystic fibrosisReview
      154. Vitamin D supplementation for cystic fibrosisReview
      155. Vitamin E supplementation in people with cystic fibrosisReview
      156. Vitamin K supplementation for cystic fibrosisReview
      157. Zinc supplements for treating thalassaemia and sickle cell diseaseReview
    3. Protocols
      1. Agents for inhibiting the adhesion of red blood cells to the endothelium in people with sickle cell diseaseProtocol
      2. Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviewsProtocolOverview
      3. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing oral or dental proceduresProtocolNew
      4. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosisProtocol
      5. Autogenic drainage for airway clearance in cystic fibrosisProtocol
      6. Biomarkers for diagnosis of Wilson's diseaseProtocolDiagnostic
      7. Bypassing agent prophylaxis in people with hemophilia A or B with inhibitorsProtocol
      8. Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion-dependent beta thalassaemiaProtocol
      9. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosisProtocol
      10. Desmopressin acetate (DDAVP) for preventing and treating bleeding in people with mild or moderate haemophilia AProtocol
      11. Drug treatments for breathlessness in end-stage cystic fibrosisProtocol
      12. Enzyme replacement therapy for infantile-onset Pompe diseaseProtocol
      13. Exercise for hemophiliaProtocol
      14. Growth hormone therapy for people with thalassaemiaProtocol
      15. Hydroxyurea for ß-thalassaemia majorProtocol
      16. Hydroxyurea for reducing blood transfusion in non-transfusion dependent beta thalassaemiasProtocol
      17. Inhaled nitric oxide for treating pain crises in people with sickle cell diseaseProtocol
      18. Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemiaProtocolNew
      19. Interventions for improving adherence to treatment in cystic fibrosisProtocol
      20. Interventions for managing advanced liver disease in cystic fibrosisProtocol
      21. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complicationsProtocol
      22. Interventions for preventing silent cerebral infarcts in people with sickle cell diseaseProtocolWithdrawn
      23. Interventions for treating pulmonary hypertension in people with sickle cell disease or thalassaemiaProtocol
      24. Long-acting inhaled bronchodilators for cystic fibrosisProtocol
      25. Magnesium for treating sickle cell diseaseProtocol
      26. Newborn screening for galactosaemiaProtocol
      27. Psychological interventions for people with hemophiliaProtocol
      28. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviewsProtocolOverview
      29. Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosisProtocolNew
      30. Vitamin D supplementation for sickle cell diseaseProtocol
  12. Cochrane Dementia and Cognitive Improvement Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Effective Practice and Organisation of Care Group
  16. Cochrane ENT Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group
  21. Cochrane Gynaecology and Fertility Group
  22. Cochrane Haematological Malignancies Group
  23. Cochrane Heart Group
  24. Cochrane Hepato-Biliary Group
  25. Cochrane HIV/AIDS Group
  26. Cochrane Hypertension Group
  27. Cochrane IBD Group
  28. Cochrane Incontinence Group
  29. Cochrane Infectious Diseases Group
  30. Cochrane Injuries Group
  31. Cochrane Kidney and Transplant Group
  32. Cochrane Lung Cancer Group
  33. Cochrane Metabolic and Endocrine Disorders Group
  34. Cochrane Methodology Review Group
  35. Cochrane Movement Disorders Group
  36. Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group
  37. Cochrane Musculoskeletal Group
  38. Cochrane Neonatal Group
  39. Cochrane Neuromuscular Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Pregnancy and Childbirth Group
  43. Cochrane Public Health Group
  44. Cochrane Schizophrenia Group
  45. Cochrane Skin Group
  46. Cochrane STI Group
  47. Cochrane Stroke Group
  48. Cochrane Tobacco Addiction Group
  49. Cochrane Upper GI and Pancreatic Diseases Group
  50. Cochrane Urology Group
  51. Cochrane Vascular Group
  52. Cochrane Work Group
  53. Cochrane Wounds Group

SEARCH